Search

The authors comment on the debate over statins as part of the standard of care for secondary prevention of coronary heart disease (CHD).

The authors comment on the need to change guidelines to prevent heart diseases among individuals in the U.S.

The authors comment on the debate between traditional risk factors alone versus risk factors plus biomarkers or imaging as a means to refine cardiovascular (CV) disease risk prediction in line with their paper on the predictive power of high-sensitivity C-reactive protein and coronary calcium.

The article comments on a report published in the "Archives of Internal Medicine" about the effects of statins on energy and fatigue with exertion on cardiac patients.